SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis

SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis

Background: Tauroselcholic [75selenium] acid (SeHCAT™) (GE Healthcare, Chicago, IL, USA) is a radiopharmaceutical that may be useful in diagnosing bile acid diarrhoea. Objectives: To assess the clinical effectiveness and cost-effectiveness of SeHCAT for the investigation of adults with chronic unexp...

Full description

Bibliographic Details
Main Authors: Marie Westwood, Isaac Corro Ramos, Nigel Armstrong, Edyta Ryczek, Hannah Penton, Marscha Holleman, Caro Noake, Maiwenn Al
Format: Article
Language:English
Published: NIHR Journals Library 2022-11-01
Series:Health Technology Assessment
Subjects:
bile acids
diarrhoea
malabsorption
chronic disease
diagnosis
irritable bowel syndrome
crohn’s disease
Online Access:https://doi.org/10.3310/JTFO0945

Internet

https://doi.org/10.3310/JTFO0945

Similar Items